BioSenic and Pluristyx sign term sheet for market : comparem

INSIDE INFORMATION Potential license agreement to produce and commercialize original and transformed ALLOB cells BioSenic to potentially receive royalty...

Related Keywords

Paris , France General , France , Belgium , Mont Saint Guibert , Waals Gewest , Belgian , French , Annie Florence Loyer , Bert Bouserie , Neil Hunter Michelle Boxall , Seitosei Actifin , Ghislaine Gasparetto , Mahendra Rao , Biosenic Pluristyx , International Media Enquiries , Ib Communications , Cell Bank , Euronext Brussels , Mesenchymal Stem Cells , Bone Therapeutics , Implant Therapeutics , Implant Therapeutic Induced Pluripotent Stem Cell , Chief Executive Officer , Vice President , Arsenic Trioxide , Host Disease , Systemic Sclerosis , Louvain La Neuve Science Park , Mesenchymal Stromal Cells , Graft Versus Host Disease , Systemic Lupus , Chief Executive , Belgian Media , Investor Enquiries , French Media Enquiries , French Investor Enquiries , Brussels Stock Exchange Bios , Biosenic ,